Switch to:
Genomic Health Inc (NAS:GHDX)
EV/EBITDA
-29.60 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Genomic Health Inc's enterprise value is $718.1 Mil. Genomic Health Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2015 was $-24.3 Mil. Therefore, Genomic Health Inc's EV/EBITDA ratio for today is -29.60.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Genomic Health Inc's stock price is $26.62. Genomic Health Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2015 was $-0.85. Therefore, Genomic Health Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Genomic Health Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=718.084/-24.261
=-29.60

Genomic Health Inc's current Enterprise Value is $718.1 Mil.
Genomic Health Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2015 was -2.878 (Jun. 2014 ) + -4.128 (Sep. 2014 ) + -4.314 (Dec. 2014 ) + -12.941 (Mar. 2015 ) = $-24.3 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Genomic Health Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=26.62/-0.847
=

Genomic Health Inc's share price for today is $26.62.
Genomic Health Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2015 was -0.15 (Jun. 2014 ) + -0.2 (Sep. 2014 ) + -0.197 (Dec. 2014 ) + -0.3 (Mar. 2015 ) = $-0.85.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Genomic Health Inc Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebitda -6.58-15.39-22.35-46.30-235.2748.4942.0851.54-145.40-54.33

Genomic Health Inc Quarterly Data

Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15
ev2ebitda 51.5462.17111.02167.03-145.40-62.10-57.57-40.93-54.33-35.23
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK